NCT07322003 Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS Status RECRUITING Phase PHASE3
NCT07312240 LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS Status RECRUITING Phase NA
NCT07302321 Needs of ALS Patients With C9orf72 Mutation and Their Caregivers Status RECRUITING Phase N/A
NCT07290062 A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS) Status RECRUITING Phase PHASE1
NCT07287397 Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS Status RECRUITING Phase PHASE1/PHASE2
NCT07259980 A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS) Status RECRUITING Phase N/A
NCT07224269 Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis Status RECRUITING Phase EARLY_PHASE1
NCT07224256 VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration Status RECRUITING Phase NA
NCT07223723 A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT07221240 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis Status RECRUITING Phase PHASE1
NCT07204977 Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07193953 Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07178574 Polish Version Dyspnea in Amyotrophic Lateral Sclerosis Status NOT_YET_RECRUITING Phase N/A
NCT07178067 Longitudinal Evaluation of Short-Chain Fatty Acid Profiles During the Natural Disease Course and a Mediterranean Diet Intervention in Amyotrophic Lateral Sclerosis Patients Status COMPLETED Phase N/A
NCT07095712 Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS Status COMPLETED Phase PHASE1/PHASE2
NCT07095686 Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS Status ENROLLING_BY_INVITATION Phase PHASE1/PHASE2
NCT07093268 Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis Status NOT_YET_RECRUITING Phase PHASE1
NCT06977451 Personalized Antisense Oligonucleotide for a Single Participant With CHCHD10 ALS Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06973629 Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY) Status NOT_YET_RECRUITING Phase PHASE3